Posts Tagged ‘STEMI’

February 4th, 2015

Clinical Significance of Non-IRA Disease in STEMI Patients

Beat Meyer wonders whether and how an observed association between the presence of non-IRA lesions and increased mortality in STEMI patients will affect treatment decisions.

February 2nd, 2015

Selections from Richard Lehman’s Literature Review: February 2nd

This week’s topics include less-tight vs. tight hypertension control in pregnancy, icatibant for ACE-inhibitor-induced angioedema, and more.

December 15th, 2014

The Latest on Culprit-Vessel vs. Multivessel Primary PCI for STEMI


We interview Bilal Iqbal about his real-world observational analysis of culprit-vessel vs. multivessel intervention at the time of primary PCI for STEMI.

November 26th, 2014

Resolving the Questions About Door-to-Balloon Times

Brahmajee K. Nallamothu discusses his research group’s retrospective study of changes, over time, in the relation between door-to-balloon times and mortality after primary PCI.

November 24th, 2014

Selections from Richard Lehman’s Literature Review: November 24th

This week’s topics include the PROTECT-AF trial, the association of inpatient vs. outpatient onset of STEMI with treatment and clinical outcomes, and more.

October 27th, 2014

Case: When an “Inappropriate” Stress Test Might Be Appropriate


Jean-Pierre Usdin presents the case of a 58-year-old man with well-treated hypertension who experiences an ST-segment-elevation MI shortly after a stress test he had requested to clear him for exercise.

September 15th, 2014

Selections from Richard Lehman’s Literature Review: September 15th

This week’s topics include prehospital ticagrelor in STEMI, ivabradine in stable CAD without clinical HF, FFR-guided PCI for stable CAD, and more.

September 1st, 2014

New Support For Complete Revascularization During Primary PCI

Until recently, MI patients receiving emergency PCI would only have the culprit artery opened. Complete revascularization of non-infarct-related arteries was performed later. The conventional wisdom was that revascularization of non-infarct-related arteries could be dangerous. That wisdom began to change last year with the PRAMI trial, which found no evidence of harm and a suggestion of benefit in […]

June 30th, 2014

Registry Study Offers Reassurance About Newer Drug-Eluting Stents

Findings from a large ongoing registry study provide some reassurance about the long-term safety of new-generation drug-eluting stents (DES)  in patients with STEMI who undergo primary PCI. The results are published online in the Journal of the American College of Cardiology. SCAAR (Swedish Coronary Angiography and Angioplasty Registry) investigators analyzed data from 34,000 primary PCI patients who […]

June 24th, 2014

In Emerging China, STEMI Admissions Skyrocket But Treatment Lags

Accompanying all the other changes in China over the past decade, admission to the hospital for ST-segment elevation MI (STEMI) has soared, according to a paper published in the Lancet. Although the study finds that there have been some genuine improvements in treatment, the Chinese healthcare system still has a long way to go to improve […]